News - Management, Oncology

Filter

Current filters:

ManagementOncology

Popular Filters

SillaJen changes its name to mark Jennerex acquisition

20-06-2014

South Korean privately held pharma company SillaJen has changed its name to SillaJen Biotherapeutics…

Asia-PacificJennerexManagementMergers & AcquisitionsOncologyPexa-VecPharmaceuticalSillaJen

Novartis outlines aims to be more profitable and increasingly focused

Novartis outlines aims to be more profitable and increasingly focused

19-06-2014

Swiss drug major Novartis has set out its new focused portfolio at the first Meet Novartis Management…

EuropeManagementNovartisOncologyOphthalmicsPharmaceutical

Novartis nabs Merck's Bruno Strigini as president of oncology business

Novartis nabs Merck's Bruno Strigini as president of oncology business

01-06-2014

Swiss pharma major Novartis has announced the appointment of Bruno Strigini as president of Novartis…

BoardroomManagementOncologyPharmaceutical

Bristol-Myers Squibb refocuses R&D strategy

Bristol-Myers Squibb refocuses R&D strategy

08-11-2013

US drug major Bristol-Myers Squibb says it is “evolving its strategic focus in R&D to ensure continued…

Anti-viralsBristol-Myers SquibbDiabetesManagementNeurologicalOncologyPharmaceuticalResearch

AVEO Oncology restructuring and job cuts as tivozanib future in RCC in doubt

05-06-2013

Following a recent negative opinion on its lead product candidate from a Food and Drug Administration…

Astellas PharmaAVEO OncologyBiotechnologyFinancialManagementOncologyResearchtivozanib

Affymax slashes workforce following Omontys problems; evaluating options

19-03-2013

US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…

AffymaxBiotechnologyFinancialManagementOmontysOncologyPharmaceutical

Roche granted EU approval for Perjeta; board appointments

06-03-2013

The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…

BiotechnologyEuropeManagementOncologyPerjetaPharmaceuticalRegulationRoche

Pharmaceutical sales rep access reducing most among oncologists in USA

28-08-2012

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives…

BiotechnologyManagementMarkets & MarketingNorth AmericaOncologyPharmaceutical

Dainippon Sumitomo to set up DSP Cancer Institute

21-08-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says it plans to establish a new organization…

BiotechnologyDainippon Sumitomo PharmaManagementOncologyPharmaceuticalResearch

Myrexis to drop development of Azixa; 4th-qtr loss widens; names new CEO

13-09-2011

US biotech firm Myrexis (Nasdaq: MYRX), previously known as Myriad Pharmaceuticals, saw its shares fall…

FinancialImmunologicalsManagementMyrexisMyriad PharmaceuticalsOncologyPharmaceuticalResearch

Dendreon to slash 25% of work force under restructuring plan; updates on Provenge

12-09-2011

US biotech firm Dendreon (Nasdaq: DNDN), which last month scaled back expectations for its novel prostate…

BiotechnologyDendreonFinancialGlaxoSmithKlineManagementOncologyPharmaceuticalProvenge

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top